Egan RW - Search Results

1

Identification of two H3-histamine receptor subtypes.

West RE Jr, Zweig A, Shih NY, Siegel MI, Egan RW, Clark MA. West RE Jr, et al. Among authors: egan rw. Mol Pharmacol. 1990 Nov;38(5):610-3. Mol Pharmacol. 1990. PMID: 2172771

2

Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).

McLeod RL, Rizzo CA, West RE Jr, Aslanian R, McCormick K, Bryant M, Hsieh Y, Korfmacher W, Mingo GG, Varty L, Williams SM, Shih NY, Egan RW, Hey JA. McLeod RL, et al. Among authors: egan rw. J Pharmacol Exp Ther. 2003 Jun;305(3):1037-44. doi: 10.1124/jpet.103.049254. Epub 2003 Mar 20. J Pharmacol Exp Ther. 2003. PMID: 12649305

3

High affinity histamine H3 receptors regulate ACTH release by AtT-20 cells.

Clark MA, Korte A, Myers J, Egan RW. Clark MA, et al. Among authors: egan rw. Eur J Pharmacol. 1992 Jan 7;210(1):31-5. doi: 10.1016/0014-2999(92)90648-n. Eur J Pharmacol. 1992. PMID: 1318202

4

Characterization of a digitonin-solubilized bovine brain H3 histamine receptor coupled to a guanine nucleotide-binding protein.

Zweig A, Siegel MI, Egan RW, Clark MA, Shorr RG, West RE Jr. Zweig A, et al. Among authors: egan rw. J Neurochem. 1992 Nov;59(5):1661-6. doi: 10.1111/j.1471-4159.1992.tb10996.x. J Neurochem. 1992. PMID: 1328529

5

Characterization and tissue distribution of H3 histamine receptors in guinea pigs by N alpha-methylhistamine.

Korte A, Myers J, Shih NY, Egan RW, Clark MA. Korte A, et al. Among authors: egan rw. Biochem Biophys Res Commun. 1990 May 16;168(3):979-86. doi: 10.1016/0006-291x(90)91125-c. Biochem Biophys Res Commun. 1990. PMID: 2161226

6

Biexponential kinetics of (R)-alpha-[3H]methylhistamine binding to the rat brain H3 histamine receptor.

West RE Jr, Zweig A, Granzow RT, Siegel MI, Egan RW. West RE Jr, et al. Among authors: egan rw. J Neurochem. 1990 Nov;55(5):1612-6. doi: 10.1111/j.1471-4159.1990.tb04946.x. J Neurochem. 1990. PMID: 2213013

7

Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.

Billah MM, Chapman RW, Egan RW, Gilchrest H, Piwinski JJ, Sherwood J, Siegel MI, West RE Jr, Kreutner W. Billah MM, et al. Among authors: egan rw. J Pharmacol Exp Ther. 1990 Mar;252(3):1090-6. J Pharmacol Exp Ther. 1990. PMID: 2319461

8

Guanine nucleotides and pertussis toxin reduce the affinity of histamine H3 receptors on AtT-20 cells.

Clark MA, Korte A, Egan RW. Clark MA, et al. Among authors: egan rw. Agents Actions. 1993 Nov;40(3-4):129-34. doi: 10.1007/BF01984051. Agents Actions. 1993. PMID: 8023737

9

Steroid-sensitivity of agonist binding to pituitary cell line histamine H3 receptors.

West RE Jr, Myers J, Zweig A, Siegel MI, Egan RW, Clark MA. West RE Jr, et al. Among authors: egan rw. Eur J Pharmacol. 1994 May 17;267(3):343-8. doi: 10.1016/0922-4106(94)90160-0. Eur J Pharmacol. 1994. PMID: 8088374

10

Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.

Hey JA, Aslanian R, Bolser DC, Chapman RW, Egan RW, Rizzo CA, Shih NY, Fernandez X, McLeod RL, West R, Kreutner W. Hey JA, et al. Among authors: egan rw. Arzneimittelforschung. 1998 Sep;48(9):881-8. Arzneimittelforschung. 1998. PMID: 9793613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters